Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00134381 · ClinicalTrials.gov registry record · Phase 2
Green Tea and Ultraviolet Light-induced Skin Damage
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT00134381 is a Phase 2 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 68 participants.
The verdict
NCT00134381, a Phase 2 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether topically applied constituents of green tea \[caffeine or (-)-epigallocatechin gallate; EGCG\] have a protective effect on skin exposed to ultraviolet light (UV).
Interventions
- DRUG Placebo
- DRUG Green Tea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2003-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00134381
The ClinicalTrials.gov registry entry for NCT00134381 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00134381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00134381 about?
NCT00134381 is a clinical study titled "Green Tea and Ultraviolet Light-induced Skin Damage". The purpose of this study is to investigate whether topically applied constituents of green tea \[caffeine or (-)-epigallocatechin gallate; EGCG\] have a protective effect on skin exposed to ultraviolet light (UV).
What is the current status of trial NCT00134381?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2003-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00134381?
The interventions under investigation include: Placebo (DRUG), Green Tea (DRUG).
Who is sponsoring clinical trial NCT00134381?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.